<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:creator>Bahi, Amine</dc:creator>
  <dc:creator>Boyer, Frederic</dc:creator>
  <dc:creator>Kafri, Tal</dc:creator>
  <dc:creator>Dreyer, Jean-Luc</dc:creator>
  <dc:date>2006-07-20</dc:date>
  <dc:description xmlns:ns0="xml" ns0:lang="en">Serine proteases in the nervous system have functional roles in neural plasticity. Among them, urokinase-type plasminogen activator (uPA) exerts a variety of functions during development, and is involved in learning and memory. Furthermore, psychostimulants strongly induce uPA expression in the mesolimbic dopaminergic pathway. In this study, doxycycline-regulatable lentiviruses expressing either uPA, a dominant-negative form of uPA, or non-regulatable lentiviruses expressing small interfering RNAs (siRNAs) targeted against uPA have been prepared and injected into the ventral tegmental area (VTA) of rat brains. Over-expression of uPA in the VTA induces doxycycline-dependent expression of its receptor, uPAR, but not its inhibitor, plasminogen activator inhibitor-1 (PAI-1). uPAR expression in the VTA is repressed upon silencing of uPA with lentiviruses expressing siRNAs. In addition, over-expression of uPA in the VTA promotes a 15-fold increase in locomotion activity upon cocaine delivery. Animals expressing the dominant-negative form of uPA did not display such hyperlocomotor activity. These cocaine-induced behavioural changes, associated with uPA expression, could be suppressed in the presence of doxycycline or uPA-specific siRNAs expressing lentiviruses. These data strongly support the major role of urokinase in cocaine-mediated plasticity changes.</dc:description>
  <dc:format>application/pdf</dc:format>
  <dc:identifier>https://folia.unifr.ch/global/documents/300249</dc:identifier>
  <dc:identifier>https://folia.unifr.ch/documents/300249/files/dreier_suv.pdf</dc:identifier>
  <dc:language>eng</dc:language>
  <dc:relation>info:eu-repo/semantics/altIdentifier/doi/10.1111/j.1471-4159.2006.04013.x</dc:relation>
  <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
  <dc:rights>License undefined</dc:rights>
  <dc:source>Journal of Neurochemistry. - 2006, vol. 98, no. 5, p. 1619–1631</dc:source>
  <dc:subject xmlns:ns1="xml" ns1:lang="en">addiction</dc:subject>
  <dc:subject xmlns:ns2="xml" ns2:lang="en">in vivo gene transfer</dc:subject>
  <dc:subject xmlns:ns3="xml" ns3:lang="en">lentivirus</dc:subject>
  <dc:subject xmlns:ns4="xml" ns4:lang="en">plasticity</dc:subject>
  <dc:subject xmlns:ns5="xml" ns5:lang="en">small interfering RNA</dc:subject>
  <dc:subject xmlns:ns6="xml" ns6:lang="en">urokinase-type plasminogen activator</dc:subject>
  <dc:subject>info:eu-repo/classification/udc/57</dc:subject>
  <dc:title xmlns:ns7="xml" ns7:lang="en">Silencing urokinase in the ventral tegmental area in vivo induces changes in cocaine-induced hyperlocomotion</dc:title>
  <dc:type>http://purl.org/coar/resource_type/c_6501</dc:type>
</oai_dc:dc>
